Rhumbline Advisers Sight Sciences, Inc. Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 54,311 shares of SGHT stock, worth $386,151. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,311
Previous 54,597
0.52%
Holding current value
$386,151
Previous $225,000
17.33%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SGHT
# of Institutions
84Shares Held
20.6MCall Options Held
0Put Options Held
0-
Kck Ltd. Tortola, D84.37MShares$31.1 Million100.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.19MShares$22.7 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.12MShares$15.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.91MShares$13.6 Million0.0% of portfolio
-
Americana Partners, LLC Houston, TX1.23MShares$8.74 Million0.14% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $340M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...